<!-- Counter 18 — Sequência terapêutica: do anabólico à manutenção -->
<section
  class="slide"
  data-slide=""
  data-title="Sequência terapêutica: do anabólico à manutenção"
  id="slide-treatment-sequence"
  style="padding: 32px 44px 16px 44px; background: var(--bg);"
>
  <div style="display: flex; flex-direction: column; height: 100%; box-sizing: border-box;">
  <!-- Eyebrow -->
  <p
    style="
      font-family: var(--font-sans);
      font-size: 0.72vw;
      font-weight: 700;
      text-transform: uppercase;
      letter-spacing: 0.06em;
      color: var(--muted);
      margin: 0 0 4px 0;
    "
  >
    Sequência terapêutica
  </p>

  <!-- Title -->
  <h1
    style="
      font-family: var(--font-sans);
      font-size: 2.1vw;
      font-weight: 800;
      color: var(--navy);
      line-height: 1.1;
      margin: 0 0 0.5vw 0;
      letter-spacing: -0.01em;
    "
  >
    Do anabólico à manutenção: a ordem importa
  </h1>

  <!-- 3-phase timeline -->
  <div style="display: grid; grid-template-columns: 1fr 1fr 1fr; gap: 0.6vw; margin-bottom: 0.45vw">
    <!-- Phase 1: Anabólico - border differentiates from blunting effect -->
    <div
      style="background: var(--navy); border: 2px solid rgba(var(--gold-rgb), 0.3); border-radius: 0.5vw; padding: 0.7vw 0.8vw; display: flex; flex-direction: column"
    >
      <div style="display: flex; align-items: center; gap: 0.35vw; margin-bottom: 0.2vw">
        <span
          style="
            font-family: var(--font-sans);
            font-size: 0.58vw;
            font-weight: 700;
            color: var(--navy);
            background: var(--gold);
            padding: 0.1vw 0.35vw;
            border-radius: 0.18vw;
            text-transform: uppercase;
          "
        >
          Fase 1
        </span>
        <span style="font-family: var(--font-sans); font-size: 0.58vw; color: rgba(255, 255, 255, 0.5)">
          12-24 meses
        </span>
      </div>
      <p
        style="font-family: var(--font-sans); font-size: 1vw; font-weight: 800; color: var(--gold); margin: 0 0 0.3vw 0"
      >
        Construir
      </p>
      <div
        style="
          background: rgba(255, 255, 255, 0.06);
          border-radius: 0.22vw;
          padding: 0.5vw 0.6vw;
          margin-bottom: 0.25vw;
        "
      >
        <p
          style="
            font-family: var(--font-sans);
            font-size: 0.85vw;
            font-weight: 700;
            color: rgba(255, 255, 255, 0.95);
            margin: 0;
          "
        >
          Romosozumabe 210 mg/mês SC
        </p>
        <p
          style="
            font-family: var(--font-sans);
            font-size: 0.6vw;
            color: rgba(255, 255, 255, 0.55);
            margin: 0.08vw 0 0 0;
            line-height: 1.35;
          "
        >
          12 meses (máximo) · dual: formação ↑ + reabsorção ↓
        </p>
      </div>
      <div
        style="
          background: rgba(255, 255, 255, 0.04);
          border-radius: 0.22vw;
          padding: 0.4vw 0.6vw;
          margin-bottom: 0.2vw;
        "
      >
        <p
          style="
            font-family: var(--font-sans);
            font-size: 0.65vw;
            font-weight: 600;
            color: rgba(255, 255, 255, 0.7);
            margin: 0;
            line-height: 1.35;
          "
        >
          Único anabólico aprovado ANVISA/ANS
        </p>
      </div>
      <div
        style="background: rgba(var(--gold-rgb), 0.1); border-radius: 0.18vw; padding: 0.3vw 0.5vw; margin-top: auto"
      >
        <p style="font-family: var(--font-sans); font-size: 0.6vw; font-weight: 700; color: var(--gold); margin: 0">
          Ganho DMO 12m: +6% quadril · +13% coluna
        </p>
        <p
          style="
            font-family: var(--font-sans);
            font-size: 0.52vw;
            color: rgba(255, 255, 255, 0.45);
            margin: 0.04vw 0 0 0;
          "
        >
          Paciente naive (FRAME) — ganho máximo
        </p>
      </div>
    </div>

    <!-- Phase 2: Consolidação -->
    <div
      style="
        background: var(--white);
        border: 1.5px solid var(--border);
        border-radius: 0.5vw;
        padding: 0.7vw 0.8vw;
        display: flex;
        flex-direction: column;
      "
    >
      <div style="display: flex; align-items: center; gap: 0.35vw; margin-bottom: 0.2vw">
        <span
          style="
            font-family: var(--font-sans);
            font-size: 0.58vw;
            font-weight: 700;
            color: var(--white);
            background: var(--navy);
            padding: 0.1vw 0.35vw;
            border-radius: 0.18vw;
            text-transform: uppercase;
          "
        >
          Fase 2
        </span>
        <span style="font-family: var(--font-sans); font-size: 0.58vw; color: var(--muted)">3-6 anos</span>
      </div>
      <p
        style="font-family: var(--font-sans); font-size: 1vw; font-weight: 800; color: var(--navy); margin: 0 0 0.3vw 0"
      >
        Consolidar
      </p>
      <div
        style="
          background: rgba(var(--navy-rgb), 0.03);
          border-radius: 0.22vw;
          padding: 0.35vw 0.5vw;
          margin-bottom: 0.2vw;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.75vw; font-weight: 700; color: var(--navy); margin: 0">
          Zoledronato 5 mg IV anual
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.55vw; color: var(--muted); margin: 0.04vw 0 0 0">
          3a (6a se risco persistente) · permite drug holiday
        </p>
      </div>
      <div
        style="
          background: rgba(var(--navy-rgb), 0.03);
          border-radius: 0.22vw;
          padding: 0.35vw 0.5vw;
          margin-bottom: 0.2vw;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.75vw; font-weight: 700; color: var(--navy); margin: 0">
          Denosumabe 60 mg SC 6/6m
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.55vw; color: var(--muted); margin: 0.04vw 0 0 0">
          Sem drug holiday (risco de rebound vertebral)
        </p>
      </div>
      <!-- Warning: rebound -->
      <div
        style="
          background: rgba(var(--navy-rgb), 0.06);
          border-left: 0.15vw solid var(--navy);
          border-radius: 0.22vw;
          padding: 0.35vw 0.5vw;
          margin-bottom: 0.2vw;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.62vw; font-weight: 700; color: var(--navy); margin: 0">
          ⚠ Descontinuação denosumabe
        </p>
        <p
          style="
            font-family: var(--font-sans);
            font-size: 0.55vw;
            color: var(--muted);
            margin: 0.04vw 0 0 0;
            line-height: 1.3;
          "
        >
          <strong style="color: var(--navy)">Sempre</strong>
          transicionar para zoledronato. Suspensão = rebound vertebral (Tsourdi JBMR 2017).
        </p>
      </div>
      <div
        style="background: rgba(var(--teal-rgb), 0.04); border-radius: 0.18vw; padding: 0.3vw 0.5vw; margin-top: auto"
      >
        <p style="font-family: var(--font-sans); font-size: 0.6vw; font-weight: 700; color: var(--teal); margin: 0">
          Meta: manter DMO e prevenir fraturas
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.52vw; color: var(--muted); margin: 0.04vw 0 0 0">
          Romo→Zol: mantém 73% do ganho em 12m (Cosman 2024)
        </p>
      </div>
    </div>

    <!-- Phase 3: Monitoramento -->
    <div
      style="
        background: var(--white);
        border: 1.5px solid var(--border);
        border-radius: 0.5vw;
        padding: 0.7vw 0.8vw;
        display: flex;
        flex-direction: column;
      "
    >
      <div style="display: flex; align-items: center; gap: 0.35vw; margin-bottom: 0.2vw">
        <span
          style="
            font-family: var(--font-sans);
            font-size: 0.58vw;
            font-weight: 700;
            color: var(--white);
            background: var(--teal);
            padding: 0.1vw 0.35vw;
            border-radius: 0.18vw;
            text-transform: uppercase;
          "
        >
          Fase 3
        </span>
        <span style="font-family: var(--font-sans); font-size: 0.58vw; color: var(--muted)">Contínuo</span>
      </div>
      <p
        style="font-family: var(--font-sans); font-size: 1vw; font-weight: 800; color: var(--teal); margin: 0 0 0.3vw 0"
      >
        Monitorar
      </p>
      <div
        style="
          background: rgba(var(--teal-rgb), 0.04);
          border-radius: 0.22vw;
          padding: 0.45vw 0.55vw;
          margin-bottom: 0.25vw;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.78vw; font-weight: 700; color: var(--navy); margin: 0">
          DXA 1-2a + marcadores ósseos
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.58vw; color: var(--muted); margin: 0.08vw 0 0 0; line-height: 1.35">
          P1NP/CTX para monitorar reativação em drug holiday
        </p>
      </div>
      <div
        style="
          background: rgba(var(--teal-rgb), 0.04);
          border-radius: 0.22vw;
          padding: 0.45vw 0.55vw;
          margin-bottom: 0.25vw;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.78vw; font-weight: 700; color: var(--teal); margin: 0">
          Atingiu meta? → drug holiday
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.58vw; color: var(--muted); margin: 0.08vw 0 0 0; line-height: 1.35">
          Apenas bifosfonatos (ver slide T-score →)
        </p>
      </div>
      <div
        style="
          background: rgba(var(--teal-rgb), 0.04);
          border-radius: 0.22vw;
          padding: 0.45vw 0.55vw;
          margin-bottom: 0.25vw;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.78vw; font-weight: 700; color: var(--navy); margin: 0">
          Não atingiu? → intensificar
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.58vw; color: var(--muted); margin: 0.08vw 0 0 0; line-height: 1.35">
          AR potente (zoledronato) ou 2º curso anabólico
        </p>
      </div>
      <div
        style="background: rgba(var(--navy-rgb), 0.05); border-radius: 0.22vw; padding: 0.4vw 0.55vw; margin-top: auto"
      >
        <p style="font-family: var(--font-sans); font-size: 0.65vw; font-weight: 700; color: var(--navy); margin: 0">
          Osteoporose = doença crônica
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.55vw; color: var(--muted); margin: 0.06vw 0 0 0">
          Nunca "alta" — reavaliação contínua
        </p>
      </div>
    </div>
  </div>

  <!-- Blunting effect — HERO PROTAGONISTA -->
  <div
    style="
      background: var(--navy);
      border-radius: 0.55vw;
      padding: 0.9vw 1.2vw;
      margin-bottom: 0.5vw;
      display: flex;
      align-items: center;
      gap: 1.2vw;
    "
  >
    <div style="flex-shrink: 0; min-width: 7vw">
      <p
        style="
          font-family: var(--font-sans);
          font-size: 0.7vw;
          font-weight: 800;
          text-transform: uppercase;
          letter-spacing: 0.04em;
          color: var(--gold);
          margin: 0 0 0.15vw 0;
        "
      >
        Blunting effect
      </p>
      <p style="font-family: var(--font-sans); font-size: 0.58vw; color: rgba(255,255,255,0.65); margin: 0; line-height: 1.3">
        AR prévio atenua<br/>resposta ao anabólico
      </p>
    </div>
    <!-- 3 context cards - HIGH CONTRAST with border accent -->
    <div style="display: flex; gap: 0.7vw; flex: 1">
      <div
        style="
          flex: 1;
          background: var(--white);
          border-radius: 0.35vw;
          padding: 0.55vw 0.7vw;
          text-align: center;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.6vw; font-weight: 700; color: var(--teal); margin: 0">Naive (FRAME)</p>
        <p
          style="
            font-family: var(--font-serif);
            font-size: 1.5vw;
            font-weight: 800;
            color: var(--navy);
            margin: 0.1vw 0 0 0;
            line-height: 1;
          "
        >
          +6% · +13%
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.52vw; color: var(--muted); margin: 0.08vw 0 0 0">quadril · coluna</p>
      </div>
      <div
        style="
          flex: 1;
          background: var(--white);
          border: 2px solid var(--gold);
          border-radius: 0.35vw;
          padding: 0.55vw 0.7vw;
          text-align: center;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.6vw; font-weight: 700; color: var(--gold-dark); margin: 0">
          Pós-alendronato
        </p>
        <p
          style="
            font-family: var(--font-serif);
            font-size: 1.5vw;
            font-weight: 800;
            color: var(--navy);
            margin: 0.1vw 0 0 0;
            line-height: 1;
          "
        >
          +3% · +10%
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.55vw; font-weight: 700; color: #c0392b; margin: 0.08vw 0 0 0">
          −50% resposta
        </p>
      </div>
      <div
        style="
          flex: 1;
          background: var(--white);
          border: 3px solid var(--gold-dark);
          border-radius: 0.35vw;
          padding: 0.55vw 0.7vw;
          text-align: center;
        "
      >
        <p style="font-family: var(--font-sans); font-size: 0.6vw; font-weight: 700; color: var(--gold-dark); margin: 0">
          Pós-denosumabe
        </p>
        <p
          style="
            font-family: var(--font-serif);
            font-size: 1.5vw;
            font-weight: 800;
            color: var(--navy);
            margin: 0.1vw 0 0 0;
            line-height: 1;
          "
        >
          +1% · +5%
        </p>
        <p style="font-family: var(--font-sans); font-size: 0.55vw; font-weight: 700; color: #c0392b; margin: 0.08vw 0 0 0">
          −85% resposta
        </p>
      </div>
    </div>
    <div style="flex-shrink: 0; text-align: center; padding: 0 0.3vw">
      <p
        style="
          font-family: var(--font-sans);
          font-size: 0.95vw;
          font-weight: 800;
          color: var(--gold);
          margin: 0;
          line-height: 1.2;
        "
      >
        Anabólico primeiro<br/>= máxima resposta
      </p>
    </div>
  </div>

  <!-- Take-home -->
  <div
    style="
      background: var(--navy);
      border-radius: 0.45vw;
      padding: 0.6vw 1.1vw;
      display: flex;
      align-items: center;
      gap: 0.8vw;
      margin-bottom: 0.5vw;
    "
  >
    <span
      style="
        font-family: var(--font-sans);
        font-size: 0.6vw;
        font-weight: 700;
        color: var(--navy);
        background: var(--gold);
        padding: 0.18vw 0.45vw;
        border-radius: 0.22vw;
        text-transform: uppercase;
        letter-spacing: 0.04em;
        flex-shrink: 0;
      "
    >
      Takeaway
    </span>
    <p
      style="
        font-family: var(--font-sans);
        font-size: 0.78vw;
        font-weight: 500;
        color: var(--white);
        margin: 0;
        line-height: 1.3;
      "
    >
      Osteoporose é tratamento
      <strong style="color: var(--gold)">sequencial</strong>
      : construir → consolidar → monitorar. Anabólico primeiro em naive. Nunca interromper sem plano de transição.
    </p>
  </div>

  <!-- References -->
  <p style="font-family: var(--font-sans); font-size: 0.52vw; color: var(--muted); margin: 0; line-height: 1.4">
    Cosman F et al. JBMR 2024;39(10):1393-1405. Leder BZ et al. Lancet 2015;386:1147-55. Tsourdi E et al. JBMR
    2017;32:1291-6. Langdahl BL et al. Lancet 2017;390:1585-94 (STRUCTURE).
  </p>
  </div>
</section>
